Key Details
Annual ROE
-125.38%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Nov 11, 2022Recent annual earnings:
Aug 11, 2022Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Apr 10, 2017Analyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with GBS included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
GBS doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS)
GBS
globenewswire.com16 December 2024
Real-World Evidence Study Strengthens the Body of Evidence Supporting ANX005 for Treatment of GBS ANX005 Phase 3 Population Was Matched 1:1 on Prespecified Criteria with Patients in International GBS Outcomes Study (IGOS) Matched Cohort Study Showed Early and Greater Benefits of ANX005 over IVIg or PE in Muscle Strength and Functional Outcomes Across Multiple Measurements Conference Call and Webcast Today at 8:30 a.m. ET BRISBANE, Calif.
FAQ
- What is the primary business of GBS?
- What is the ticker symbol for GBS?
- Does GBS pay dividends?
- What sector is GBS in?
- What industry is GBS in?
- What country is GBS based in?
- When did GBS go public?
- Is GBS in the S&P 500?
- Is GBS in the NASDAQ 100?
- Is GBS in the Dow Jones?
- When was GBS's last earnings report?
- When does GBS report earnings?
What is the primary business of GBS?
GBS Inc. operates as a biosensor diagnostic technology company. Its principal product is Saliva Glucose Biosensor, a saliva glucose monitoring system for diabetes management. The company also focuses on developing other diagnostic tests in the areas of biochemistry, tumor markers, immunology, hormones, and other biomarkers. It has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. GBS Inc. was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was founded in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
What is the ticker symbol for GBS?
The ticker symbol for GBS is NASDAQ:GBS
Does GBS pay dividends?
No, GBS does not pay dividends
What sector is GBS in?
GBS is in the Healthcare sector
What industry is GBS in?
GBS is in the Medical Devices industry
What country is GBS based in?
GBS is headquartered in United States
When did GBS go public?
GBS's initial public offering (IPO) was on 23 December 2020
Is GBS in the S&P 500?
No, GBS is not included in the S&P 500 index
Is GBS in the NASDAQ 100?
No, GBS is not included in the NASDAQ 100 index
Is GBS in the Dow Jones?
No, GBS is not included in the Dow Jones index
When was GBS's last earnings report?
GBS's most recent earnings report was on 11 November 2022
When does GBS report earnings?
The date for GBS's next earnings report has not been announced yet